What are examples of drugs with a wide therapeutic index?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drugs with a Wide Therapeutic Index

Selective Serotonin Reuptake Inhibitors (SSRIs), proton pump inhibitors (PPIs), statins, ACE inhibitors, and levetiracetam are examples of drugs with wide therapeutic indices that offer greater flexibility in dosing and reduced risk of toxicity. 1

Definition and Clinical Significance

A wide therapeutic index indicates that a drug has a significant margin between doses that produce therapeutic effects and those that cause toxicity. This contrasts with narrow therapeutic index (NTI) drugs, which have small differences between therapeutic and toxic doses 2.

Drugs with wide therapeutic indices offer several clinical advantages:

  • Greater flexibility in dosing for special populations including elderly, pediatric, and patients with renal or hepatic impairment 1
  • Less susceptibility to changes in absorption due to food interactions, genetic polymorphisms affecting metabolism, and moderate changes in organ function 1
  • Reduced need for intensive therapeutic drug monitoring compared to NTI drugs 3
  • Lower risk of serious adverse events from minor dosing variations 4

Examples of Drugs with Wide Therapeutic Index

Psychiatric/Neurological Medications

  • SSRIs (fluoxetine, citalopram, escitalopram) have wider therapeutic indices compared to older antidepressants 1
  • Levetiracetam has a relatively wide therapeutic index compared to other anti-seizure medications like phenytoin or carbamazepine 1

Gastrointestinal Medications

  • Proton pump inhibitors (omeprazole, pantoprazole) have wide therapeutic indices 1
  • H2 receptor antagonists (ranitidine, famotidine) demonstrate wide therapeutic indices 1

Respiratory Medications

  • Albuterol and other beta-2 agonists have relatively wide therapeutic indices 1

Cardiovascular Medications

  • Statins (HMG-CoA reductase inhibitors) have wide therapeutic indices 1
  • ACE inhibitors demonstrate wide therapeutic indices 1

Other Common Medications

  • Acetaminophen (at recommended doses) has a wide therapeutic index 1
  • Most non-sedating antihistamines have wide therapeutic indices 1

Clinical Applications and Advantages

Wide therapeutic index drugs are particularly valuable in several clinical scenarios:

  • Preferred when patient compliance may be variable 1
  • Advantageous in patients with multiple comorbidities or polypharmacy 1
  • Beneficial when drug interactions are likely 1
  • Allow for more aggressive dose rounding (up to 10-20%) without significant risk of adverse effects, particularly in pediatric populations 1
  • Reduced need for intensive monitoring compared to NTI drugs like aminoglycosides, digoxin, warfarin, and phenytoin 3

Contrast with Narrow Therapeutic Index Drugs

Unlike drugs with wide therapeutic indices, NTI drugs:

  • Require more intensive monitoring to avoid toxicity 3
  • Are associated with significantly more drug-related problems (DRPs) 3
  • Often require therapeutic drug monitoring 5
  • Have higher "drug risk ratios" (number of drug-related problems divided by number of times used) 3
  • Are more frequently associated with non-optimal dosing, drug interactions, and need for monitoring 3

Practical Considerations

For many drugs with wide therapeutic indices, a fixed adult dose is adequate with minimal toxicity profile 4. This contrasts with NTI drugs where small changes in systemic concentration can lead to significant changes in pharmacodynamic response, potentially resulting in subtherapeutic or toxic effects 2.

When selecting medications, particularly for patients with variable compliance, multiple comorbidities, or those on multiple medications, drugs with wider therapeutic indices generally offer a safer profile with less need for intensive monitoring 1.

References

Guideline

Drugs with a Wide Therapeutic Index

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of narrow therapeutic index drugs.

Journal of thrombosis and thrombolysis, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Novel bioequivalence approach for narrow therapeutic index drugs.

Clinical pharmacology and therapeutics, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.